Tenderwize
Back to tender search

Open house discount agreements Adalimumab (ATC L04AB04)

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jul 03, 2027 · 320 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Adalimumab, ATC L04AB04

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated value or framework maximum amount is provided. The actual business volume is unknown.

The open-house contract can be automatically suspended if AOK Bayern enters into a national or regional discount agreem...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Provision of pharmaceutical product Adalimumab (ATC L04AB04) under a discount agreement with AOK Bayern.
  • Non-exclusive, open-house model where all eligible pharmaceutical companies can participate.
Show full summary

This is an open-house model (not a classic procurement procedure) by AOK Bayern for non-exclusive discount agreements on the active substance Adalimumab (ATC L04AB04). Any eligible pharmaceutical company can join by submitting a signed declaration of reliability and the contract. The agreement runs from September 1, 2025, to August 31, 2027, with the possibility to join at any time until July 3, 2027. No estimated value is provided.

Risks

No estimated value or framework maximum amount is provided. The actual business volume is unknown.

The open-house contract can be automatically suspended if AOK Bayern enters into a national or regional discount agreem...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company.

Administrative

  • Submit a signed declaration of reliability.
  • Submit the signed contract and annex listing the covered medicines.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house discount agreements Adalimumab (ATC L04AB04)

Non-exclusive discount agreement for Adalimumab (ATC L04AB04) with a duration from 01.09.2025 to 31.08.2027. All eligible pharmaceutical companies can join. The contract is identical for all participants.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Deadline

Deadline Jul 03, 2027

Procurement Details

Publication date
13 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
458658-2025

Documents (2)

Similar tenders